Awake Nasal Intubation in Laryngopharyngeal Tumors

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 20, 2018

Primary Completion Date

November 20, 2018

Study Completion Date

December 25, 2018

Conditions
Airway Management
Interventions
DEVICE

fiberoptic naso-tracheal intubation

The trachea will be intubated under direct fiberoptic view after a fiberoptic upper airway examination. The flexible nasolaryngoscope will be armed with an intubating tube and passed inside tracheal lumen trough one of the nostrils.

DRUG

Topical anaesthesia

Topical anaesthesia with lidocaine will be provided through nebulisation and instillation. The intubating tube will be lubricated with a gel containing lidocaine.

DRUG

Light sedation

The patient will be sedated with a combination of midazolam, fentanyl administered intravenously in small boluses until the desired level of sedation is achieved as expressed of The Observer's Assessment of Alertness/Sedation Scale (OAA/S) of 4 or 5.

Trial Locations (1)

400006

Cluj County Emergency Hospital- ENT Clinic, Cluj-Napoca

All Listed Sponsors
lead

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

NCT03546088 - Awake Nasal Intubation in Laryngopharyngeal Tumors | Biotech Hunter | Biotech Hunter